202 / 1851
CARs are artificial receptors that can be constructed by linking
the variable regions of the antibody heavy and light chains to
intracellular signaling chains (such as CD3-zeta, CD28, 41BB)
alone or in combination with other signaling moieties.
CARs recognize antigens that do not need
to be MHC-restricted, but they must be
presented on the tumor cell surface.